Breakthrough Achievement: First mRNA RSV Vaccine Receives FDA Approval

MedPage Today) — The FDA approved the first-ever mRNA-1345 vaccine (mRESVIA) for respiratory syncytial virus (RSV) for people ages 60 and older to protect against lower respiratory tract disease, Moderna announced Friday in a press release…
Source : MedPageToday